Skip to main content

Medicine Matters branded image Welcome

We provide news, expert interviews, and educational resources to help you keep up with the latest developments in oncology

2021 ASCO Annual Meeting coverage

Access news and expert commentary from the 2021 ASCO Annual Meeting

FEATURED NEWS | Genitourinary cancers

04-06-2021 | ASCO 2021 | Conference coverage | News

KEYNOTE-564 supports adjuvant pembrolizumab use in high-risk RCC patients

Postoperative treatment with pembrolizumab significantly improves the disease-free survival of patients with high-risk, clear cell renal cell carcinoma relative to placebo, show trial data.

FEATURED NEWS | Lung & thoracic cancers

04-06-2021 | ASCO 2021 | Conference coverage | News

Adjuvant atezolizumab delays recurrence in early-stage NSCLC patients

People with stage II–IIIA non-small-cell lung cancer derive a significant disease-free survival benefit from adjuvant treatment with atezolizumab versus best supportive care, according to phase 3 trial results.

Stay informed with Medicine Matters

Get the latest developments in breast, lung, & GU cancers delivered straight to your inbox

FEATURED NEWS | Breast cancer

08-06-2021 | ASCO 2021 | Conference coverage | News

‘Excellent’ outcomes with de-escalated neoadjuvant early breast cancer regimen

A de-escalated neoadjuvant regimen of pertuzumab and trastuzumab plus paclitaxel leads to “excellent” pathologic complete response rates and survival in people with hormone receptor-negative, HER2-positive early breast cancer, phase 2 study findings indicate.


12-05-2021 | COVID-19 | News

COVID-19 leaves large cancer screening deficit in USA

Breast, prostate, and colorectal cancer screening rates declined sharply during the initial months of the COVID-19 pandemic in the USA, and while they subsequently recovered, a large deficit remains, study findings indicate.


Interviews with clinical experts on cancer patient care

Image Credits